Delivery Order SPE2DR25D2103-SPE2DR26F91PX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9,872.70 to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 27 mg, a controlled-release methylphenidate medication used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by August 18, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency's Medical Supply Chain awarded a $5,190.36 delivery order to AmerisourceBergen Drug Corp for Concerta ER Tablets 36mg, a controlled-release methylphenidate medication used to treat attention-deficit/hyperactivity disorder. This firm fixed-price delivery order, issued on October 29, 2025, represents a competitive award with no set-aside designation and is scheduled for completion by October 30, 2025. The order will be fulfilled from AmerisourceBergen's corporate...
- The Defense Logistics Agency Medical Supply Chain awarded a $21,395.38 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Concerta ER Tabs 36mg, a controlled-release methylphenidate medication used to treat attention-deficit/hyperactivity disorder. The contract is a firm fixed price delivery order with an ultimate completion date of July 21, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This award was competitively awarded...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,010.89 to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 54 mg, a prescription medication used to treat attention deficit hyperactivity disorder. This competitively awarded, firm fixed-price delivery order was issued on October 23, 2025, with an ultimate completion date of October 24, 2025, and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The place of...
- The U.S. Defense Department's Medical Supply Chain awarded a $45,744.59 delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Concerta ER Tabs 36mg, a controlled-release methylphenidate medication used to treat attention deficit hyperactivity disorder. This non-set-aside, competitively awarded contract employs firm fixed pricing and is classified as a delivery order under a larger indefinite delivery contract vehicle. Performance will be executed from...
- The Defense Logistics Agency awarded a delivery order valued at $7,260.40 to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 27 mg on April 23, 2025, with completion scheduled for April 24, 2025. This firm fixed price delivery order is non-set-aside and represents a competitive award to the pharmaceutical distributor for a controlled-release methylphenidate product used in the treatment of attention deficit hyperactivity disorder. The order will be fulfilled from AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $10,745.29 to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 36 mg on July 21, 2025, with completion expected by July 22, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitively awarded pharmaceutical supply transaction fulfilling federal medical procurement requirements. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Concerta ER Tablets 36mg, a controlled-release methylphenidate medication used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order, valued at $67,832.46, represents a competitively awarded, non-set-aside contract with an ultimate completion date of August 28, 2025. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency awarded a $3,301.25 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 36 mg, with an ultimate completion date of July 25, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 1, 2025, for the supply of Concerta ER Tablets 36mg, a controlled-release methylphenidate product commonly used for attention deficit hyperactivity disorder treatment. This firm fixed-price delivery order, valued at $17,783.70 with an ultimate completion date of July 2, 2025, was competitively awarded without set-aside provisions and will be performed at the contractor's...
- SPE2DR25D2103Indefinite Delivery Contract
- SPE2DR25D2103-SPE2DR26F91PXDelivery Order
The Defense Logistics Agency awarded a $9,598.74 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 36 mg, a controlled-release methylphenidate medication used to treat attention-deficit/hyperactivity disorder. This competitively awarded, firm fixed-price delivery order, issued on November 5, 2025, will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility and is scheduled for completion by November 6, 2025. No small business set-aside was utilized for this procurement. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that serves as a global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical federal vendor supplying an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.6k | 11/5/25 |